retatrutide clinical trials phase 3 Lilly orforglipron oral GLP-1 weight loss trial Eli Lilly's triple hormone drug

Journal of Physiology Paris 93:501504 Radeljak S, Seiwerth S, Sikiric P (2004) BPC 157 inhibits cell growth and VEGF signalling via the MAPK kinase pathway in the human melanoma cell line

[93] Veterinary patients with the condition share many of the same clinical signs as their human counterparts, including progressive exercise intolerance, increased respiratory rate, and eventual respiratory distress

So Ill just leave that there

( f-g ) Cells were treated with the IDH1 inhibitor ( f ) or cultured under glutamine starvation ( g ) and treated cisplatin (Cis) alone and in combination with or without l-carnitine supplementation (n = 4 technical replicates representative from 3 independent experiments)